Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · IEX Real-Time Price · USD
4.850
-0.060 (-1.22%)
At close: May 3, 2024, 4:00 PM
4.940
+0.090 (1.86%)
After-hours: May 3, 2024, 6:27 PM EDT

Ventyx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
3421461,857999--
Market Cap Growth
--92.15%85.92%---
Enterprise Value
101-951,541740124
PE Ratio
-0.76-0.76-17.13-11.71--
PB Ratio
1.400.605.253.58--
P/FCF Ratio
-0.87-0.87-18.75-25.67--
P/OCF Ratio
-0.88-0.88-18.80-25.84--
EV/EBITDA Ratio
0.490.49-14.27-8.85-0.45-0.85
EV/EBIT Ratio
0.490.49-14.21-8.85-0.45-0.85
EV/FCF Ratio
0.570.57-15.56-19.03-2.00-1.34
Debt / Equity Ratio
0.050.050.00--0.41-0.93
Debt / EBITDA Ratio
-0.07-0.07-0.01--0.45-0.92
Debt / FCF Ratio
-0.07-0.07-0.02--2.04-1.46
Quick Ratio
11.3711.3719.4421.050.170.49
Current Ratio
11.8711.8720.2121.410.180.55
Interest Coverage
----844.92-77.70-28.64
Return on Equity (ROE)
-62.90%-62.90%-35.00%-68.60%162.00%-
Return on Assets (ROA)
-57.70%-57.70%-32.60%-58.50%-9486.20%-
Return on Capital (ROIC)
-81.11%-81.11%-31.83%-24.05%39.15%1482.27%
Earnings Yield
-56.43%-132.30%-5.84%-8.54%--
FCF Yield
-48.85%-114.53%-5.33%-3.90%--
Buyback Yield / Dilution
-11.57%-11.57%-309.11%-544.96%-19.66%-
Total Shareholder Return
-11.57%-11.57%-309.11%-544.96%-19.66%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).